{
    "nctId": "NCT03004209",
    "officialTitle": "Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients",
    "inclusionCriteria": "* Clinically diagnosed autoimmune encephalitis\n* Ineffective 1st line treatment (e.g. steroid IV, IVIg) and 2nd line treatment (e.g. Rituximab or cyclophosphamide)\n* Must have minimum age of 18 Years\n* Must have maximum age of 85 Years",
    "exclusionCriteria": "* Hemoglobin \\> 12g/dL\n* Hematochrit \\>36%\n* Thrombocytosis \\> 750K\n* AST or ALT \\> 120\n* HIV (+)\n* Allergic reaction upon erythropoietin\n* Uncontrolled hypertension\n* mRS before the autoimmune encephalitis \\> 3\n* Breast feeding or pregnancy\n* History of ischemic stroke or pulmonary thrombosis\n* Refuse to be enrolled"
}